Gottardo NG. Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas: "it's a numbers game"-implications for WNT medulloblastoma dose-reduction clinical trials. Acta Neuropathol 2022 Nov 20. doi: 10.1007/s00401-022-02518.
PMID: 36403175